In most renal cell carcinomas, sarcomas, lung adenocarcinomas and various additional tumors, NRP1 levels were significantly increased in tumor versus normal tissue, in contrast to reduced expression in certain other tumors e.g. breast cancer versus normal (Additional file 1: Figure S5A). This evidence concerns the gene NRP1 and breast carcinoma.